Hodgkin's disease, clinical stages IA to IIIB: combined modality therapy (3 MOPP followed by curative and prophylactic radiotherapy including the spleen) . Six-year results
Colonna, P.; Andrieu, J.M.; Ghouadni, R.; Zouaoui-Benhadji, Z.; Afiane, M.; Kubisz, P.; Tourani, J.M.; Belhadj-Merzoug, K.; Schlienger, M.
European Journal of Haematology 39(4): 356-361
1987
ISSN/ISBN: 0902-4441 PMID: 3691758 DOI: 10.1111/j.1600-0609.1987.tb00783.x
Accession: 040296113
Full-Text Article emailed within 0-6 h
Payments are secure & encrypted
Summary
From January 1980 to September 1985, 82 patients with IA to IIIB clinical stage (CS) Hodgkin's disease were treated by three MOPP chemotherapy (CT) cycles followed by extended field radiotherapy (RT) including the spleen (30-40 Gy). 2 patients died during the treatment (medullary aplasia, pulmonary edema). 6 were in failure after three MOPP cycles; they received other CT; 3 died and 3 are alive in remission (survival: 2.5 to 3.5 yr). 74 were in complete remission (CR) after completion of treatment. 4 patients relapsed (all alive after re-treatment) and 4 died in first CR (tuberculosis, hepatitis, myeloma, unknown cause). At 6 yr, actuarial survival and relapse-free survival are respectively 89.8% for the 82 patients and 93% for those in CR. These good results are due to: the administration of CT before RT, limited to three cycles; identification of failures after CT; inclusion of the spleen in RT ports in all cases; and a short lumbo-aortic port in CS I and II.